BEIJING, March 9, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) (“Nuokang” or the “Company”), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products, today announced that it plans to release its fourth quarter and full year 2009 financial results after the market closes on Tuesday, March 16, 2010.
